Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT06436183

Public ClinicalTrials.gov record NCT06436183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Randomized, Double-blind, 16-week Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

Study identification

NCT ID
NCT06436183
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Apollo Therapeutics Ltd
Industry
Enrollment
62 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2024
Primary completion
Mar 25, 2025
Completion
Aug 11, 2025
Last update posted
Sep 17, 2025

2024 – 2025

United States locations

U.S. sites
30
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Medical Dermatology Specialists, PC/US Dermatology Partners Phoenix Arizona 85006
California Dermatology & Clinical Research Institute Encinitas California 92024
First OC Dermatology Research, Inc. Fountain Valley California 92708
Center for Dermatology Clinical Research, Inc. Fremont California 94538
California Allergy and Asthma Medical Group Los Angeles California 90025
University of California Los Angeles Dermatology Los Angeles California 90095
Amicis Research Center (Northridge) Northridge California 91324
Cura Clinical Research Oxnard California 93030
VASDHS - Veterans Affairs San Diego Medical Center San Diego California 92161
Clinical Sciences Institute Santa Monica California 90404
Renaissance Research and Medical Group Cape Coral Florida 33991
D&H National Research Centers, Inc. Miami Florida 33155
Avita Clinical Research - Dermatology Tampa Florida 33613
Sneeze, Wheeze & Itch Associates, LLC Normal Illinois 61761
Dawes Fretzin Clinical Research Indianapolis Indiana 46250
Skin Sciences, PLLC Louisville Kentucky 40217
Owensboro Dermatology Associates Owensboro Kentucky 42303
Revival Research Institute Troy Michigan 48084
Somerset Skin Centre Troy Michigan 48084
Michigan Dermatology Institute Waterford Michigan 28329
Advanced Dermatology and Skin Cancer Center - Saint Joseph Saint Joseph Missouri 64506
Skin Specialists PC Omaha Nebraska 68144
M3 Wake Research, Inc. Raleigh North Carolina 27612
ObjectiveHealth-The Skin Surgery Center for Clinical Research Winston-Salem North Carolina 27103
Central Sooner Research Oklahoma City Oklahoma 73071
Unity Clinical Research - Dermatology Oklahoma City Oklahoma 73118
Paddington Testing Co. Inc Philadelphia Pennsylvania 19103
Rodgers Dermatology Frisco Texas 75034
Center for Clinical Studies Houston Texas 77004
Clinical Trial Network Houston Texas 77074

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06436183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2025 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06436183 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →